{"id":444976,"date":"2025-09-23T05:09:10","date_gmt":"2025-09-23T05:09:10","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/444976\/"},"modified":"2025-09-23T05:09:10","modified_gmt":"2025-09-23T05:09:10","slug":"irelands-viagra-village-in-the-eye-of-trumps-tariff-storm-politico-eu","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/444976\/","title":{"rendered":"Ireland\u2019s \u2018Viagra Village\u2019 in the eye of Trump\u2019s tariff storm – politico.eu"},"content":{"rendered":"
    \n
  1. Ireland\u2019s \u2018Viagra Village\u2019 in the eye of Trump\u2019s tariff storm<\/a>  politico.eu<\/li>\n
  2. What Trends Are You Seeing in Pharma Commercialization?<\/a>  PharmExec<\/li>\n
  3. Ireland faces tougher pharma investment battle as US tariffs bite, Inizio\u2019s new boss warns<\/a>  Business Post<\/li>\n
  4. What Challenges and Opportunities Are There in the Commercialization Space?<\/a>  PharmExec<\/li>\n
  5. Transitioning from COO to CEO<\/a>  PharmExec<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Ireland\u2019s \u2018Viagra Village\u2019 in the eye of Trump\u2019s tariff storm  politico.eu What Trends Are You Seeing in Pharma Commercialization?  PharmExec…\n","protected":false},"author":2,"featured_media":444977,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[1204,2437,6641,30,4230,32,1214,1195,105,33190,4348,18109,475,806,1302,1197,678,5167,4326,5769,11665,23908,14948,51250,10057,23422,33591,479,1200,1201,16,15,49],"class_list":{"0":"post-444976","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-cancer","9":"tag-companies","10":"tag-competitiveness","11":"tag-courts","12":"tag-cycling","13":"tag-donald-trump","14":"tag-exports","15":"tag-growth","16":"tag-health","17":"tag-health-professionals-workforce","18":"tag-healthcare","19":"tag-higher-education","20":"tag-imports","21":"tag-industry","22":"tag-innovation","23":"tag-investment","24":"tag-ireland","25":"tag-manufacturing","26":"tag-medication","27":"tag-medicines","28":"tag-meps","29":"tag-michael-mcgrath","30":"tag-oncology","31":"tag-patents","32":"tag-pharma","33":"tag-roads","34":"tag-sean-kelly","35":"tag-tariffs","36":"tag-tax","37":"tag-trade","38":"tag-uk","39":"tag-united-kingdom","40":"tag-united-states"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115251889007740905","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/444976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=444976"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/444976\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/444977"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=444976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=444976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=444976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}